← Back to directory

Werner Poewe

Researcher Next ID · RN-024334

Researcher · Medicine

Innsbruck Medical University

Innsbruck, Austria

Not currently recruitingFunding unknown
Works count
1,032
Citation count
118,855
H-index
154
i10-index
666

Research interests

Medicine
Neuroscience
Parkinson's Disease Mechanisms and Treatments
Neurological disorders and treatments
Genetic Neurodegenerative Diseases
Botulinum Toxin and Related Neurological Disorders
Restless Legs Syndrome Research

Publications

  • The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

    Movement Disorders · 2022 · https://doi.org/10.1002/mds.29005

  • Challenges in the diagnosis of Parkinson's disease

    The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00030-2

  • Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Movement Disorders · 2017 · https://doi.org/10.1002/mds.26987

  • Parkinson disease

    Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.13

  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Movement Disorders · 2017 · https://doi.org/10.1002/mds.27115

  • MDS research criteria for prodromal Parkinson's disease

    Movement Disorders · 2015 · 10.1002/mds.26431

  • MDS clinical diagnostic criteria for Parkinson's disease

    Movement Disorders · 2015 · https://doi.org/10.1002/mds.26424

  • Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

    Glia · 2012 · 10.1002/glia.22437

  • The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

    Movement Disorders · 2011 · 10.1002/mds.23884

  • A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

    The American Journal of Human Genetics · 2011 · 10.1016/j.ajhg.2011.06.008

  • The Parkinson Progression Marker Initiative (PPMI)

    Progress in Neurobiology · 2011 · 10.1016/j.pneurobio.2011.09.005

  • A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

    New England Journal of Medicine · 2009 · 10.1056/nejmoa0809335

  • Non‐motor symptoms in Parkinson’s disease

    European Journal of Neurology · 2008 · 10.1111/j.1468-1331.2008.02056.x

  • Second consensus statement on the diagnosis of multiple system atrophy

    Neurology · 2008 · https://doi.org/10.1212/01.wnl.0000324625.00404.15

  • Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

    Movement Disorders · 2008 · https://doi.org/10.1002/mds.22340

  • Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

    Movement Disorders · 2007 · 10.1002/mds.21844

  • Clinical diagnostic criteria for dementia associated with Parkinson's disease

    Movement Disorders · 2007 · https://doi.org/10.1002/mds.21507

  • Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan

    Movement Disorders · 2006 · 10.1002/mds.21198

  • A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease

    New England Journal of Medicine · 2006 · 10.1056/nejmoa060281

  • Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia

    New England Journal of Medicine · 2006 · 10.1056/nejmoa063618

  • Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

    The Lancet · 2005 · 10.1016/s0140-6736(05)71083-7

  • The diagnosis of Parkinson's disease

    The Lancet Neurology · 2005 · 10.1016/s1474-4422(05)70285-4

  • Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease

    Circulation · 2004 · 10.1161/01.cir.0000127957.43874.bb

  • Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease

    Movement Disorders · 2004 · 10.1002/mds.20213

  • Rivastigmine for Dementia Associated with Parkinson's Disease

    New England Journal of Medicine · 2004 · 10.1056/nejmoa041470

  • Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study

    Annals of Neurology · 2003 · 10.1002/ana.10609

  • Early consolidation in human primary motor cortex

    Nature · 2002 · 10.1038/nature712

Current projects

    No projects listed.